Mar 28, 2022 9:25am EDT Artelo Expands Collaboration with Trinity College Dublin to Investigate Cellular Biology of Fatty Acid Binding Protein (FABP) Inhibition In Cancer
Mar 22, 2022 9:00am EDT Artelo Biosciences to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th
Mar 21, 2022 8:30am EDT Artelo Biosciences Reports Four-Month 2021 Financial Results in Connection with its Amended Fiscal Year End and Provides Business Update
Mar 02, 2022 8:30am EST Artelo Biosciences Receives Notice of Allowance for Method-of-Use Patent in the United States for ART12.11, a Proprietary Cocrystal of Cannabidiol
Jan 12, 2022 8:30am EST Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update
Jan 11, 2022 8:30am EST Artelo Anticipates Accelerated Clinical Development for ART27.13 Following Its Classification Change in the United Kingdom
Jan 10, 2022 9:00am EST Artelo Biosciences Leadership to Participate on Endocannabinoid Panel at the H.C. Wainwright BioConnect 2022 Virtual Conference
Nov 29, 2021 8:30am EST Artelo Biosciences Reports Fiscal 2021 Year-End Financial Results and Provides Business Update
Sep 08, 2021 8:30am EDT Artelo Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
